How Much Can You Save?
Speak With a Copay Assistance Specialist
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances.
Get Started in Minutes
How Injectafer Copay Assistance Works
1 – Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
2 – Transfer Prescription to AmeriPharma
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
3 – Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
4 – Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.
5 – Nursing Care Coordination
AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
6 – Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
Speak With a Specialist
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
What Is Injectafer?
Injectafer (generic name: ferric carboxymaltose) is an iron replacement medication that is administered intravenously as directed by a physician.
This therapy has been approved in pediatric patients who are at least 1 year of age or in adults who have an intolerance to oral iron supplements, have had an unsatisfactory response to oral iron, or have non-dialysis-dependent chronic kidney disease.
Schedule a Consultation
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
What Is Injectafer Used to Treat?
Injectafer has been FDA approved to treat Iron-Deficiency Anemia.
However, it can also be administered for off-label indications such as abdominal surgery (perioperative anemia management), chemotherapy-associated anemia, iron-deficiency anemia in inflammatory bowel disease, iron-deficiency in heart failure with reduced ejection fraction, and restless leg syndrome.
Your physician will determine if this therapy is appropriate for you to use based on your signs and symptoms and clinical diagnosis.
Injectafer Warnings and Precautions
- Hypersensitivity reactions: Patients should be monitored for any signs and symptoms of hypersensitivity before and after each Injectafer infusion. An observation period of 30 minutes is recommended to ensure the patient is stable upon completion.
- Symptomatic hypophosphatemia: Patients should have their phosphate levels closely monitored while on Injectafer infusions.
- Hypertension: Patients should monitor their blood pressure closely following each infusion.
Copay and Financial Assistance
AmeriPharma Specialty Care alleviates financial burdens for patients and their families
Advanced software locates funding sources to match you with top-dollar foundation programs
One of our copay assistance specialists will assist with the application process
Automatic updates will be sent to you and your physician on the status of the funding
Speak With a Specialist
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
Injectafer Side Effects
Some of the listed side effects include:
- Nausea
- Hypertension
- Flushing
- Low phosphate levels
- Dizziness
However, this medication is generally well tolerated and many patients experience little to no side effects upon initiating this therapy.
Schedule a Consultation
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
Injectafer Dosing Information
The recommended dosage for Injectafer is calculated and based on the patient’s body weight.
- For patients who weigh under 50 kg: Administer two doses (15mg/kg based on patients body weight per dose) of Injectafer separated by at least 7 days. It is recommended for the total cumulative dose to not exceed 1500 mg per course.
- For patients who weigh 50 kg or more: Administer two doses (750 mg per dose) of Injectafer separated by at least 7 days. It is recommended for the total cumulative dose to not exceed 1500 mg per course.
Injectafer infusions may be repeated as clinically indicated or until treatment goals are achieved.